Marissa Howard-McNatt to Humans
This is a "connection" page, showing publications Marissa Howard-McNatt has written about Humans.
Connection Strength
0.583
-
Gaffley M, Villa A, Vu T, Steelman S, Howard-McNatt M. Do All BRCA 1 and 2 Carriers with a Known and Unknown Breast Cancer Choose Bilateral Mastectomies? Am Surg. 2018 Sep 01; 84(9):1544-1545.
Score: 0.037
-
Stutsrim A, Howard-McNatt M. Pure Ductal Carcinoma in situ of the Male Breast. Am Surg. 2018 Aug 01; 84(8):e333-e334.
Score: 0.037
-
Garland M, Hsu FC, Clark C, Chiba A, Howard-McNatt M. The impact of obesity on outcomes for patients undergoing mastectomy using the ACS-NSQIP data set. Breast Cancer Res Treat. 2018 Apr; 168(3):723-726.
Score: 0.035
-
Merrill AY, Brown DR, Klepin HD, Levine EA, Howard-Mcnatt M. Outcomes after Mastectomy and Lumpectomy in Octogenarians and Nonagenarians with Early-Stage Breast Cancer. Am Surg. 2017 Aug 01; 83(8):887-894.
Score: 0.034
-
Merrill AY, White A, Howard-McNatt M. Paget's Disease of the Breast: An Institutional Review and Surgical Management. Am Surg. 2017 Mar 01; 83(3):e96-98.
Score: 0.033
-
Howard-McNatt M. Atypical Ductal Hyperplasia: What Is the Current Risk for Developing Breast Cancer? JAMA Oncol. 2017 Jan 01; 3(1):20-21.
Score: 0.033
-
Mogal HD, Clark C, Dodson R, Fino NF, Howard-McNatt M. Outcomes After Mastectomy and Lumpectomy in Elderly Patients with Early-Stage Breast Cancer. Ann Surg Oncol. 2017 Jan; 24(1):100-107.
Score: 0.032
-
Mogal H, Brown DR, Isom S, Griffith K, Howard-McNatt M. Intracystic papillary carcinoma of the breast: A SEER database analysis of implications for therapy. Breast. 2016 Jun; 27:87-92.
Score: 0.031
-
Allen S, Levine EA, Lesko N, Howard-Mcnatt M. Is Excisional Biopsy and Chemoprevention Warranted in Patients With Atypical Lobular Hyperplasia on Core Biopsy? Am Surg. 2015 Sep; 81(9):876-8.
Score: 0.030
-
Ahmed S, Lawrence J, Stewart JH, Melin S, Levine EA, Howard-McNatt M. Does age predict outcome in patients with inflammatory breast cancer? Am Surg. 2014 Aug; 80(8):E221-4.
Score: 0.028
-
Sun Y, Howard-McNatt M. Intracystic papillary carcinoma of the breast in a male patient. Am Surg. 2014 Mar; 80(3):E84-5.
Score: 0.027
-
Howard-McNatt M. Pros and cons of screening for BRCA mutations. N C Med J. 2013 Nov-Dec; 74(6):489-90.
Score: 0.026
-
Howard-McNatt M, Lawrence J, Melin SA, Levine EA, Shen P, Stewart JH. Race and recurrence in women who undergo neoadjuvant chemotherapy for breast cancer. Am J Surg. 2013 Apr; 205(4):397-401.
Score: 0.025
-
Howard-McNatt M, Forsberg C, Levine EA, DeFranzo A, Marks M, David L. Breast cancer reconstruction in the elderly. Am Surg. 2011 Dec; 77(12):1640-3.
Score: 0.023
-
Howard-McNatt M, Schroll RW, Hurt GJ, Levine EA. Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations. Am J Surg. 2011 Sep; 202(3):298-302.
Score: 0.023
-
Howard-McNatt M, Geisinger KR, Stewart JH, Shen P, Levine EA. Is intraoperative imprint cytology evaluation still feasible for the evaluation of sentinel lymph nodes for lobular carcinoma of the breast? Ann Surg Oncol. 2012 Mar; 19(3):929-34.
Score: 0.023
-
Uyesugi K, Howard-McNatt M. Bilateral synchronous breast cancer in a male. Am Surg. 2011 Jul; 77(7):E140-1.
Score: 0.022
-
Howard-McNatt M, Hughes KS, Schnaper LA, Jones JL, Gadd M, Smith BL. Breast cancer treatment in older women. Surg Oncol Clin N Am. 2005 Jan; 14(1):85-102, vi.
Score: 0.014
-
McNatt SS, Howard-McNatt M. Contemporary surgical management of obesity. W V Med J. 2002 Nov-Dec; 98(6):273-7.
Score: 0.012
-
Dupont E, Tsangaris T, Garcia-Cantu C, Howard-McNatt M, Chiba A, Berger AC, Levine EA, Gass JS, Gallagher K, Lum SS, Martinez RD, Willis AI, Pandya SV, Brown EA, Fenton A, Mendiola A, Murray M, Solomon NL, Senthil M, Ollila DW, Edmonson D, Lazar M, Namm JP, Li F, Butler M, McGowan NE, Herrera ME, Avitan YP, Yoder B, Walters LL, McPartland T, Chagpar AB. Resection of Cavity Shave Margins in Stage 0-III Breast Cancer Patients Undergoing Breast Conserving Surgery: A Prospective Multicenter Randomized Controlled Trial. Ann Surg. 2021 05 01; 273(5):876-881.
Score: 0.011
-
Merrill AY, Garland MM, Howard-McNatt M, Isnassuos M, Perry KC, Levine EA. What Is the Utility of Routine Complete Blood Count, Liver Function Tests, and Chest X-ray in the Evaluation of Patients with Clinically Node-Negative Breast Cancer? Am Surg. 2019 Jan 01; 85(1):29-33.
Score: 0.009
-
Mogal HD, Howard-McNatt M, Dodson R, Fino NF, Clark CJ. Quality of life of older African American breast cancer survivors: a population-based study. Support Care Cancer. 2017 05; 25(5):1431-1438.
Score: 0.008
-
Callender GG, Kaplan BJ, White RL, Brenin DR, Chagpar AB, Dalal KM, Howard-McNatt M, Howe J, Kim J, Kurtzman SH, Mansour JC, Mittendorf EA, Stewart JH, Temple LK, Stella P, Cummings C, Wong SL, Klimberg VS. Maintenance of certification: what everyone needs to know. Ann Surg Oncol. 2015 Apr; 22(4):1051-4.
Score: 0.007
-
Beard HR, Cantrell EF, Russell GB, Howard-McNatt M, Shen P, Levine EA. Outcome after mastectomy for ipsilateral breast tumor recurrence after breast conserving surgery. Am Surg. 2010 Aug; 76(8):829-34.
Score: 0.005
-
Kaminski JP, Case D, Howard-McNatt M, Geisinger KR, Levine EA. Sentinel lymph node intraoperative imprint cytology in patients with breast cancer-costly or cost effective? Ann Surg Oncol. 2010 Nov; 17(11):2920-5.
Score: 0.005
-
Vona-Davis L, Rose DP, Hazard H, Howard-McNatt M, Adkins F, Partin J, Hobbs G. Triple-negative breast cancer and obesity in a rural Appalachian population. Cancer Epidemiol Biomarkers Prev. 2008 Dec; 17(12):3319-24.
Score: 0.005
-
Jones JL, Hughes KS, Kopans DB, Moore RH, Howard-McNatt M, Hughes SS, Lee NY, Roche CA, Siegel N, Gadd MA, Smith BL, Michaelson JS. Evaluation of hereditary risk in a mammography population. Clin Breast Cancer. 2005 Apr; 6(1):38-44.
Score: 0.004